KYNMOBI FDA approval date
The FDA approved KYNMOBI on 21 May 2020.
- FDA approval date
- 21 May 2020
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as APOMORPHINE HYDROCHLORIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2020-05-21Day | KYNMOBI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA210875", "applicant_as_listed_by_fda": "SUMITOMO PHARMA AM", "brand_names": ["KYNMOBI"], "active_ingredients": ["APOMORPHINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200521", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |